This bill proposes the addition of a new subsection to section 43-15.3-08 of the North Dakota Century Code, which outlines prohibited acts for drug manufacturers regarding their interactions with contract pharmacies and covered entities. The bill defines key terms such as "contract pharmacy," "covered entity," and "drug," specifically relating to those participating in federal drug discount programs. It establishes that it is a class B misdemeanor for manufacturers or their affiliates to interfere with the acquisition of drugs by contract pharmacies on behalf of covered entities, restrict access to drugs, or impose unnecessary data submission requirements.

Additionally, the bill prohibits manufacturers from offering drugs in the form of rebates unless they are provided as discounts at the time of sale and comply with federal law. It clarifies that these regulations do not apply to the limited distribution of drugs as mandated by federal law. Overall, the legislation aims to protect the rights of covered entities and contract pharmacies in accessing necessary medications without undue restrictions from manufacturers.